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a crucial role in the pathogenesis of ulcer disease (1) (2) (3) (4) . However, pepsin output in gastric and duodenal ulcer patients has not been extensively studied, because its measurement is complex and time consuming (3). For evaluation of peptic activity, pepsinogen is determined in serum colorimetrically, radioimmunologically, or by enzyme-linked immunosorbent assays (5) (6) (7) (8) . However, it has yet to be definitively established whether peptic cell mass, pepsin in gastric juice, and serum pepsinogen are related. In fact, reports differ concerning the relation between pepsin in gastric juice and pepsinogen group I (PGI) in serum of patients with gastric and duodenal ulcers (9-14). It has also been suggested (13) that stimulated pepsin output and PGI represent two different cellular functions, e.g., the release of stored zymogen and its synthesis in chief cells. A different methodological approach could be to evaluate pepsinogen-pepain activity in the same biological sample. Previous data for this approach were obtained by use of fluorescent microassay regarding peptic activity in samples of human gastroduodenal mucosa obtained during upper gastrointestinal endoscopy (15, 16) . A recent paper (17) described a significant correlation between the severity of gastritis and (a) the concentration of PGI in serum, (b) the peak concentration of pepsin I in gastric juice, and (c) the PGI concentration in normal 
MaterIals and Methods
Biopsy specimens and specimens of venous blood were obtained at the time of endoscopic examination of 139 consecutive outpatients: 12 dyspeptic subjects (four men, eight women; ages 26-50 y), 34 gastric ulcer patients (24 men, 10 women; ages 22-61 y), and 93 duodenal ulcer patients (69 men, 24 women; ages 27-71 y).
The diagnosis of nonulcer dyspepsia was based on negative endoscopic findings and nonspecific histological alterations in patients with upper gastrointestinal discomfort. The ulcer patients were studied before and after the ulcers had healed.
In each patient four biopsies were taken, one each from the following sites: fundus, corpus, antrum of the stomach, and the lesser curvature of the duodenum. These specimens were immediately transferred from the forceps to a test tube containing hexane cooled to -70 #{176}C in a solid C02-acetone bath. The frozen tissues were weighed and then homogenized, while the tubes were kept in this same mixture, for 3 mm at 1500 x g (Dismembrator Omni Mixer; Oci Instruments, Waterbury, CT) in a pH 7.4, 10 mmol/L phosphate buffer containing 7 g of bovine albumin per liter.
We centrifuged the homogenate (2500 x g, 15 mm) and measured the PGI concentration in the supernate with a radioimmunoassay, using reagents from Sorin Biomedica, Saluggia, Italy. This is a double-antibody radioimmunoassay in which 1251-labeled PGI is the tracer, rabbit antihuman pepsinogen I is the standard, and swine anti-rabbit gamma globulin with polyethylene glycol is the second precipitating antibody (18). Results were expressed as milligrams per gram (net weight) of total protein in the homogenate. The protein concentration in the homogenates was determined by the method of Bradford (19) with reagents from Bio-Rad Laboratories, Milan, Italy. PGI was also evaluated in venous serum samples by use of the same radioimmunoassay, and results are expressed in micrograms per liter.
To assess any deterioration in stored samples, we measured the PGI concentration in the biopsy specimens immediately after homogenization and after seven, 14, and 21 days of storage at -20 #{176}C, i.e., in four different samples of the same specimens.
From four peptic ulcer patients we took two adjacent biopsies, to use in determining the variability of clinical data.
Results are reported as the mean ± standard deviation. For statistical analysis of the data we used the nonparametric distribution Kruskal-Wallis rank sum test and linear correlation.
Resufts
PGI determination
in homogenates was satisfactorily precise, the intra-assay coefficients of variation (CVs) ranging from 4.1% to 8.4%, the between-assay CVs from 4.6% to 9.3% ( were 91-103% of initial values, with no statistically signif. icant differences.
No significant differences were observed for the adjacent double biopsies obtained from four of the peptic ulcer patients ( Table 2 ). For dyspeptic subjects and the gastric ulcer and duodenal ulcer patients, there was a statistically significant difference between PGI concentration in the fundus and corpus as compared with that in the antrum and duodenum (Table 3 ). In contrast, we saw no significant difference among results for the three groups of patients.
No statistically significant relationship was detected between PGI concentration in serum (x) and in homogenates (y), whether we evaluated the combined results for all of the biopsies (fundus, corpus, antrum, and duodenum; y = 0.0706x + 127.13 ugfL) or separately evaluated only the PGI-producing sites (fundus y = 0.1116x + 124.26 ug/L; corpus y = 0.1537x + 125.60 g/L). Finally, values for PGI in serum and PGI in homogenates also were unrelated when the patients were divided according to diagnosis.
Discussion
Two physiological aspects must be taken into account for a correct determination of pepsinogen secretion: were not statistically significant (P >0.05). fact, they respond to different regulatory mechanisms, although it is well documented that peptic secretionis relatedto acid flow (20) .
(b) Pepsin in gastric juice and serum PGI probably reflect different cellular functions (13) .
A possible answer to these problems might be found by directly determining the stored zymogen PGI in gastric biopsies; this would exclude the influence of acid on peptic secretion (pepsinogen release and peptic activity of gastric juice are p11-dependent) and thus could give more information about the concentration of stored zymogen in chief cells.
As yet, only two studies (15, 16), both involving fluorometric assays, have been designed to evaluate potential peptic activity of pepsinogen on different substrates in biopsy specimens obtained endoscopically in patients with gastric and duodenal ulcer. Furthermore, there is only a preliminary report (17) on the determination by RIA of PGI concentration in gastric mucosa of patients with normal findings, or superficial or atrophic gastritis. Our results demonstrate that the commercial radioimmunoassay we used was precise (intra-assay CV 8.4% at 1.5 mg/g protein, 4.1% at 6.5 mg/g protein, 7.5% at 21.0 mg/g protein; between-assay CV 9.3% at 1.55 mg/g protein, 4.6% at 6.0 mg/g protein, 7.9% at 21.7 mg/g protein), and analytical recovery ranged from 94% to 102%. Moreover, results were not influenced by the sample storage, and reproducibility was good, as demonstrated by PGI determination in adjacent biopsies. Lastly, concentrations of PGI differed in the stomach and duodenum with a significant trend from the corpus-fundus to the antrum-duodenum. This coincides with the anatomical localization of chiefcells (fundus-corpus) (21) and with experimental data (16) showing a trend to increasing concentration of both pepsin and pepsinogen from antrum to fundus.
Our mean PGI concentrations did not differ significantly among gastric ulcer patients, duodenal ulcer patients, and dyspeptic subjects. These results, however, differ from those of others (16), who, using a fluorometric assay, found higher enzyme concentrations in duodenal ulcer patients. This difference in methods used and the small series of patients, together with their use of an inappropriate parametric statistical analysis, may explain the discrepancy.
Our data also demonstrate a lack of any correlation between PGI in serum and PGI in gastroduodenal biopsies: this may depend on the fact that intramucosal activated proteinases (such as lysosomal acid proteinases-cathepsin D and various uncharacterized nonpepsin proteinases) (22) nonspecifically degrade the stored zymogen. Or it may reflect the uncertain mechanisms of leakage and metabolism of serum PGI (23).
